NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Orteq Sports Medicine

Orteq Sports Medicine

Private
LondonHealthcare & Life Scienceshttps://orteq.com/

Last Round

Buyout/LBO

May 1, 2012

Est. Valuation

$50M

Total Funding Raised

$28.31M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Orteq Sports Medicine is a medical device company that develops joint preservation solutions for orthopedic and sports medicine surgeons, including its proprietary biodegradable meniscal scaffold, Actifit.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

bioresorbable scaffoldmeniscus repairorthopedic implantssports medicinetissue regenerationmeniscal scaffoldknee surgerybiomaterialsorthopedic surgerymedical devicesmeniscectomy alternativeregenerative medicineorthobiologicsknee arthroscopybio-polymer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orteq Sports Medicine Comparables

Compare Orteq Sports Medicine with similar companies based on industry and business-model similarity.

Orteq Sports Medicine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NovoPedics, Inc.
88%
Orthox
86%
NUsurface
85%

Orteq Sports Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBOMay 1, 2012
Corporate FundingJan 3, 2011
Series BOct 7, 2008
Series AJul 19, 2007

Orteq Sports Medicine Investors

Notable investors and investment history

Orteq Sports Medicine investors
InvestorRounds
Saratoga PartnersBuyout/LBO
Matignon Investissement et GestionSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors increased 223% MoM, reaching 3.9K.

  • Jan 5, 2026

    Monthly visitors grew 397% MoM, reaching 964.

Orteq Sports Medicine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orteq Sports Medicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orteq Sports Medicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range9
Year Founded2005
Last FundingMay 1, 2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.